Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M267Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M267EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M2.6ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with BBH

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

BBH is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BBH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CONDON PHILIP GPortfolio Manager 2013-11-26Buy3,000$11.75851.66 view
GABELLI MARIO JControl Person of Adviser 2013-11-26Sell35,600$21.47420.82 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$15.76609.52 view
FRIEDRICH ROMAN IIITrustee 2013-11-25Buy100$21.48420.58 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$18.19514.73 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy135$17.8528.2 view
CONDON PHILIP GPortfolio Manager 2013-11-22Buy8,500$11.8847.63 view
Dammeyer Rodney FDirector 2013-11-22Buy31,940$6.161715.26 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy107$18.06519.16 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy113$18.09518.13 view

Press Releases about BBH :

    Quarterly/Annual Reports about BBH:

      News about BBH:

      Articles On GuruFocus.com
      No related article found.

      More From Our Partners
      Best And Worst ETFs Of The Week Amid Biotech Breakout Oct 24 2014 - BENZINGA

      More From Other Websites
      Best And Worst ETFs Of The Week Amid Biotech Breakout Oct 24 2014
      Biotech ETFs Prescribe New ETFs Oct 23 2014
      [video] CDC needs to get ahead of Ebola: Cramer Oct 16 2014
      Biotech ETFs Aren’t Waving the White Flag…Yet Oct 15 2014
      [video] Market bright spots Oct 10 2014
      [video] Future of genetic testing Oct 07 2014
      The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, First... Oct 03 2014
      [video] Ebola stocks to watch Oct 01 2014
      In a Tricky Year for Momentum, This ETF Finds Success Sep 24 2014
      [video] Cramer: Stay on biotech Sep 24 2014
      [video] China very important for world growth: Cramer Sep 22 2014
      Biotech, Energy And Gold Big Winners Since 9/11/01 Sep 11 2014
      [video] Orexigen's obesity pill Sep 11 2014
      [video] Solid Venture's quest to fight DMD Sep 09 2014
      [video] Race to cure rare diseases Sep 09 2014
      Biotechnology ETFs Show Robust Health In August Sep 02 2014
      Best & worst August ETF sectors Sep 02 2014
      [video] Roche's blockbuster pharma deal Aug 25 2014
      [video] What Roche gets from InterMune Aug 25 2014
      [video] Big change for pain drugs Aug 22 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK